Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment

N Samsu - BioMed research international, 2021 - Wiley Online Library
Diabetic nephropathy (DN) is the leading cause of end‐stage renal disease worldwide.
Chronic hyperglycemia and high blood pressure are the main risk factors for the …

Management of hypertension in chronic kidney disease

D Pugh, PJ Gallacher, N Dhaun - Drugs, 2019 - Springer
Chronic kidney disease (CKD) is an increasingly prevalent condition globally and is strongly
associated with incident cardiovascular disease (CVD). Hypertension is both a cause and …

The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease

T Yang, EM Richards, CJ Pepine… - Nature Reviews …, 2018 - nature.com
Crosstalk between the gut microbiota and the host has attracted considerable attention
owing to its involvement in diverse diseases. Chronic kidney disease (CKD) is commonly …

[HTML][HTML] Update of pathophysiology and management of diabetic kidney disease

YC Lin, YH Chang, SY Yang, KD Wu, TS Chu - Journal of the formosan …, 2018 - Elsevier
Diabetic kidney disease (DKD) is a major cause of morbidity and mortality in patients with
diabetes mellitus and the leading cause of end-stage renal disease in the world. The most …

[書籍][B] Campbell Walsh Wein Urology, E-Book: 3-Volume Set

AW Partin, RR Dmochowski, LR Kavoussi, CA Peters… - 2020 - books.google.com
From the basic science underpinnings to the most recent developments in medical and
surgical care, Campbell-Walsh-Wein Urology offers a depth and breadth of coverage you …

Diabetic kidney disease: a report from an ADA Consensus Conference

KR Tuttle, GL Bakris, RW Bilous, JL Chiang… - Diabetes …, 2014 - diabetesjournals.org
The incidence and prevalence of diabetes mellitus have grown significantly throughout the
world, due primarily to the increase in type 2 diabetes. This overall increase in the number of …

ACE inhibitor benefit to kidney and cardiovascular outcomes for patients with non-dialysis chronic kidney disease stages 3–5: a network meta-analysis of randomised …

Y Zhang, D He, W Zhang, Y **ng, Y Guo, F Wang, J Jia… - Drugs, 2020 - Springer
Background The advantages of angiotensin-converting enzyme inhibitors (ACEIs) or
angiotensin II receptor blockers (ARBs) in reducing risk of cardiovascular events (CVEs) and …

[HTML][HTML] Chronic kidney disease: strategies to retard progression

MT Yan, CT Chao, SH Lin - International journal of molecular sciences, 2021 - mdpi.com
Chronic kidney disease (CKD), defined as the presence of irreversible structural or
functional kidney damages, increases the risk of poor outcomes due to its association with …

Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes

V Shivaswamy, B Boerner, J Larsen - Endocrine reviews, 2016 - academic.oup.com
Post-transplant diabetes mellitus (PTDM) is a frequent consequence of solid organ
transplantation. PTDM has been associated with greater mortality and increased infections …

Pharmacological targeting of mitochondria in diabetic kidney disease

KH Cleveland, RG Schnellmann - Pharmacological reviews, 2023 - Elsevier
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) in
the United States and many other countries. DKD occurs through a variety of pathogenic …